Summarized by Masters of Longevity from Science Daily - Health & Medicine.
A four‑week pilot trial found rapamycin increased cerebral blood flow in APOE4 carriers.
Key Takeaways
- Four weeks of low‑dose rapamycin increased cerebral blood flow.
- Women in the trial showed stronger blood flow improvements.
- Metabolic, inflammatory, and microbiome changes were also reported.
